2016
DOI: 10.1016/j.urolonc.2015.07.004
|View full text |Cite
|
Sign up to set email alerts
|

A prospective comparative analysis of the accuracy of HistoScanning and multiparametric magnetic resonance imaging in the localization of prostate cancer among men undergoing radical prostatectomy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
2
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
4
1
1

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 26 publications
1
2
0
Order By: Relevance
“…The difference, however, is that one is a positive correlation, while the other is a negative correlation. Some studies have shown that the Cho+Cr/Cit ratio in prostate cancer tissue detected by MRI was positively correlated with Gleason score [28,29]. This indicates that following Gleason score elevation, Cho peak enlarged, while Cit peak decreased in prostate cancer area, which further supported our conclusions.…”
Section: Discussionsupporting
confidence: 89%
“…The difference, however, is that one is a positive correlation, while the other is a negative correlation. Some studies have shown that the Cho+Cr/Cit ratio in prostate cancer tissue detected by MRI was positively correlated with Gleason score [28,29]. This indicates that following Gleason score elevation, Cho peak enlarged, while Cit peak decreased in prostate cancer area, which further supported our conclusions.…”
Section: Discussionsupporting
confidence: 89%
“…Finally, given that mpMRI outperforms HS for disease evaluation, the role of HS in disease detection and biopsy guidance remains dubious. [9,27,50]…”
Section: Discussionmentioning
confidence: 99%
“…Orcyzk et al compared HS disease detection in 31 men undergoing RP with preoperative multiparametric MRI (mpMRI). [27] In 31 men, 84 tumors were identified on RP. Histoscanning™ detected 36 of these, demonstrating CDR of 42.9%.…”
Section: Detection Of Prostate Cancermentioning
confidence: 99%